Loading clinical trials...
Loading clinical trials...
Phase 2 Study of Pralatrexate in Female Patients With Previously-treated Advanced or Metastatic Breast Cancer
Conditions
Interventions
Pralatrexate Injection
Vitamin B12
+1 more
Locations
14
United States
Providence Cancer Center
Portland, Oregon, United States
The West Clinic
Memphis, Tennessee, United States
Fakultní nemocnice Olomouc
Olomouc, Czechia
Multiscan, s.r.o.
Pardubice, Czechia
Fakultní nemocnice Královské Vinohrady - FNKV
Prague, Czechia
Centre Lutte Contre le Cancer Val d'Aurelle (CRLC)
Montpellier, Cedex 5, France
Start Date
March 1, 2010
Primary Completion Date
April 1, 2012
Completion Date
July 1, 2012
Last Updated
January 7, 2020
NCT05468034
NCT04541381
NCT03137095
NCT04852887
NCT07040891
NCT06393374
Lead Sponsor
Acrotech Biopharma Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions